Skip to content

Clinical trials

Completed Phase 1 Liver Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 1 Status: Completed Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20031
20041
20061
20071
20082
20096
20103
20114
20122
20132
20143
20154
20162
20172
20185
20195
20204
20213
20222
20238
20245
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed74

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim5
Bristol-Myers Squibb4
Pfizer4
AstraZeneca3
Celgene3
Sanofi3
Amgen2
Bayer2
Cumberland Pharmaceuticals2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases74
Hepatic Insufficiency8
Neoplasms6
Digestive System Diseases5
Hepatitis C5
Liver Neoplasms4
Lymphoma, Follicular4
Non-alcoholic Fatty Liver Disease4
Hepatitis B3
Hepatitis C, Chronic3

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.